Clinical Trials Directory

Trials / Completed

CompletedNCT06436170

The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome

Radial Peripapillary Vessel Density as a New Biomarker in Irvine-Gass Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
58 Years – 75 Years
Healthy volunteers
Accepted

Summary

Pseudophakic cystoid macular edema (PCME), also known as Irvine-Gass syndrome (IGS), is an accumulation of fluid in the macula that occurs after cataract surgery, with an early or late presentation (cut-off 3 months) . It is the most common cause of decreased vision after uneventful phacoemulsification, with a rare incidence of 0.1-2.35% for clinically significant PCME . Macular edema in IGS can be diagnosed and classified by optical coherence tomography (OCT), which enables its morphologic assessment. Fluorescein angiography (FA) is the gold standard to perform differential diagnosis for macular edema. To date, OCT angiography (OCTA) has been proposed to study various retinal vascular diseases. In contrast to FA, OCTA is able to visualize Radial peripapillary vessel density (RCP). The aim of this study was to investigate abnormalities in the vascular network of the optic nerve head in patients with IGS compared to healthy eyes, using OCT-A

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOCTAOCTA is a non invasive diagnostic technique to visualize RPC

Timeline

Start date
2023-07-01
Primary completion
2023-12-30
Completion
2024-04-29
First posted
2024-05-30
Last updated
2024-05-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06436170. Inclusion in this directory is not an endorsement.